Peritoneal Cavity Cancer [clinicaltrials_resource:55413a793c5a8244bbb3e8b67c6b355d]
clinicaltrials:NCT00003120Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00003450]clinicaltrials:NCT00003896Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00003944]Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer [clinicaltrials:NCT00004081]Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery [clinicaltrials:NCT00004895]Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer [clinicaltrials:NCT00005049]Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [clinicaltrials:NCT00006391]clinicaltrials:NCT00008138Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer [clinicaltrials:NCT00010179]clinicaltrials:NCT00028743Erlotinib and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00030446]Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer [clinicaltrials:NCT00030706]clinicaltrials:NCT00043082clinicaltrials:NCT00085384Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00101257]Vaccine Therapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [clinicaltrials:NCT00112957]Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer [clinicaltrials:NCT00217529]Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer [clinicaltrials:NCT00217555]Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer [clinicaltrials:NCT00217568]clinicaltrials:NCT00227721clinicaltrials:NCT00245050clinicaltrials:NCT00287859Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer [clinicaltrials:NCT00287885]Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer [clinicaltrials:NCT00303888]clinicaltrials:NCT00331422clinicaltrials:NCT00354601clinicaltrials:NCT00357448Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin [clinicaltrials:NCT00369954]clinicaltrials:NCT00436644Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy [clinicaltrials:NCT00466960]Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00536523]Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00538031]Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [clinicaltrials:NCT00550784]clinicaltrials:NCT00625092Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00652691]clinicaltrials:NCT00652899clinicaltrials:NCT00653328clinicaltrials:NCT00702299Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [clinicaltrials:NCT00748527]
condition [clinicaltrials_vocabulary:condition]
Peritoneal Cavity Cancer [clinicaltrials_resource:55413a793c5a8244bbb3e8b67c6b355d]
Bio2RDF identifier
55413a793c5a8244bbb3e8b67c6b355d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:55413a793c5a8244bbb3e8b67c6b355d
identifier
clinicaltrials_resource:55413a793c5a8244bbb3e8b67c6b355d
title
Peritoneal Cavity Cancer
@en
label
Peritoneal Cavity Cancer [clinicaltrials_resource:55413a793c5a8244bbb3e8b67c6b355d]
@en